Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Buergy

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 26, 2017
[Consolidative local therapy in oligometastatic NSCLC without progression after first-line chemotherapy]Daniel Buergy, Frederik Wenz
International Journal of Cancer|January 21, 2012
Tumor-platelet interaction in solid tumorsDaniel Buergy, Frederik Wenz, Christoph Groden, et al.
Radiation Oncology (London, England)|March 9, 2016
Overall survival after reirradiation of spinal metastases - independent validation of predictive modelsDaniel Buergy, Lena Siedlitzki, Judit Boda-Heggemann, et al.
The Lancet. Oncology|August 8, 2018
Adjuvant therapy in resectable gastric cancer-the CRITICS trialFrank Lohr, Daniel Buergy, Giuseppina de Marco, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2022
Radiotherapy and newly approved cancer drugs - A quantitative analysis of registered protocols for drugs approved for the treatment of solid tumorsLeonie Rabe, Frederik Wenz, Michael Ehmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 4, 2018
[Case series on SBRT in ventricular tachycardia reveals an impressive therapeutic effect]Daniel Buergy, Boris Rudic, Erol Tueluemen, et al.
Plos One|March 28, 2013
CD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34aSantoshi Muppala, Giridhar Mudduluru, Jörg H Leupold, et al.
Health and Quality of Life Outcomes|January 24, 2018
Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy seriesDaniel Buergy, Vincent Schneiberg, Joerg Schaefer, et al.
Radiation Oncology (London, England)|April 6, 2016
Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancerJulia Koeck, Frank Lohr, Daniel Buergy, et al.
Anticancer Research|August 1, 2018
Treatment of Adrenal Metastases with Conventional or Hypofractionated Image-guided Radiation Therapy - Patterns and OutcomesDaniel Buergy, Leonie Rabe, Kerstin Siebenlist, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 26, 2017
[Consolidative local therapy in oligometastatic NSCLC without progression after first-line chemotherapy]Daniel Buergy, Frederik Wenz
International Journal of Cancer|January 21, 2012
Tumor-platelet interaction in solid tumorsDaniel Buergy, Frederik Wenz, Christoph Groden, et al.
Radiation Oncology (London, England)|March 9, 2016
Overall survival after reirradiation of spinal metastases - independent validation of predictive modelsDaniel Buergy, Lena Siedlitzki, Judit Boda-Heggemann, et al.
The Lancet. Oncology|August 8, 2018
Adjuvant therapy in resectable gastric cancer-the CRITICS trialFrank Lohr, Daniel Buergy, Giuseppina de Marco, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2022
Radiotherapy and newly approved cancer drugs - A quantitative analysis of registered protocols for drugs approved for the treatment of solid tumorsLeonie Rabe, Frederik Wenz, Michael Ehmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 4, 2018
[Case series on SBRT in ventricular tachycardia reveals an impressive therapeutic effect]Daniel Buergy, Boris Rudic, Erol Tueluemen, et al.
Plos One|March 28, 2013
CD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34aSantoshi Muppala, Giridhar Mudduluru, Jörg H Leupold, et al.
Health and Quality of Life Outcomes|January 24, 2018
Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy seriesDaniel Buergy, Vincent Schneiberg, Joerg Schaefer, et al.
Radiation Oncology (London, England)|April 6, 2016
Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancerJulia Koeck, Frank Lohr, Daniel Buergy, et al.
Anticancer Research|August 1, 2018
Treatment of Adrenal Metastases with Conventional or Hypofractionated Image-guided Radiation Therapy - Patterns and OutcomesDaniel Buergy, Leonie Rabe, Kerstin Siebenlist, et al.
Pageof 5